Article
A comparative study on endoscopic ulcer healing of omeprazole versus rabeprazole with respect to CYP2C19 genotypic differences.
Digestive diseases and sciences - 1 Sept 2005
Ando Takashi, Kato Haruki, Sugimoto Naohito, Nagao Yasuyuki, Seto Nobuyuki, Hongo Hitoshi, Kajikawa Hirokazu, Isozaki Yutaka, Shimozawa Makoto, Naito Yuji, Yoshida Norimasa, Ishizaki Takashi, Yoshikawa Toshikazu
Abstract excerpt
Omeprazole is mainly metabolized in the liver by CYP2C19, a genetically determined enzyme, while rabeprazole is mainly nonenzymatically degraded with a minor involvement by CYP2C19. We investigated the gastric ulcer healing effect of omeprazole versus rabeprazole evaluated endoscopically with reference to the different CYP2C19 genotypes. Eighty patients with active gastric ulcer were treated with a daily dose of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
